Exencial Wealth Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-4,904
Closed -$450K – 495
2021
Q4
$450K Sell
4,904
-751
-13% -$89.8K 0.02% 329
2021
Q3
$717K Sell
5,655
-456
-7% -$66.4K 0.03% 214
2021
Q2
$1.02M Buy
6,111
+787
+15% +$128K 0.05% 228
2021
Q1
$967K Buy
5,324
+2,391
+82% +$555K 0.06% 221
2020
Q4
$586K Buy
2,933
+852
+41% +$173K 0.04% 231
2020
Q3
$456K Buy
+2,081
New +$441K 0.02% 269

Other funds holding TDOC

Exencial Wealth Advisors's TDOC Position: Q1 2022 in Review

Exencial Wealth Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 4,904 shares — an estimated $450K sold.

Exencial Wealth Advisors first reported a position in TDOC in Q3 2020 and held it in 6 quarters. The position peaked at $1.02M in Q2 2021. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Exencial Wealth Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Exencial Wealth Advisors sold 4,904 Teladoc Health shares in Q1 2022, an estimated $450K.
  • Exencial Wealth Advisors first reported a position in Teladoc Health in Q3 2020 and held it in 6 quarters.
  • Exencial Wealth Advisors's Teladoc Health position peaked at $1.02M in Q2 2021.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Exencial Wealth Advisors's 13F filing for Q1 2022, filed 12 May 2022.